Month: October 2011

Lacer will launch in January an innovative probiotic that contributes to reduce the cholesterol in blood by 14%.

|

Lacer will launch in January an innovative probiotic that helps to reduce cholesterol in the blood in a 14%

following the agreement reached with the biotech AB-BIOTICS.

-the company will distribute Primacol ® exclusively on Spain

Barcelona, 2011-October the pharmaceutical division of laboratories Lacer, Lacer Farma, specialist in cardiovascular health, market starting next January an innovative probioticcapable of reducing total cholesterol in the blood by 14%. The launch is the result of the agreement reached with the biotech AB-Biotics for distribution in exclusive of probiotic AB-Life in Spain, Lacer Farma will sell under the trade name Primacol ®.

Probiotic Primacol ® formula has been created from three strains of Lactobacillus plantarum, selected from over 500 strains. Thanks to this combination of bacteria, which are usually found in the intestines of healthy people, Primacol ® favors the precipitation of bile salts, hindering resorption of cholesterol in the intestine, resulting in a greater uptake of plasma cholesterol by the liver to synthesize new bile salts. Therefore, total cholesterol in the blood, either dietary source of endogenous production, looks
decreased.

Clinical studies show by AB-Biotics in the Hospital, gate iron Madrid, volunteers aged between 18 and 65 years with a cholesterol level above 200 mg/dl, the consumption of Primacol ®, which will be available in capsules, he managed to reduce total cholesterol in the blood by 14%. This order reductions represent a decrease of more than 28% of cardiovascular risk, according to epidemiological studies and clinical trials available.

For the Director General of Lacer Farma, José Miguel Noriega, ” as specialists in cardiovascular health, we are aware that high cholesterol is one of the risk factors most important to a large part of the population. The incorporation of Primacol ® to our range of products of diagnosis, prevention and reduction of cardiovascular risk, allows us to make available to one of the most comprehensive therapeutic arsenals health professionals in this field ’ ’.

The launch of Primacol ® is part of the strategy of the company to focus on the health problems from a global perspective, patient-centred. As explained by José Miguel Noriega, ‘ ’ to pharmaceutical products to combat various cardiovascular risk factors, such as hypertension and Dyslipidemia, have recently added equipment for measuring and monitoring of blood pressure, as well as pharmaceutical care related cardiovascular risk. Now, with Primacol ®, incorporate a dietary supplement that will help to reduce cholesterol levels of everyone concerned for their health cardiovascular. ”

data of the Spanish society of physicians in primary care (SEMERGEN) established that you between 50% and 70% of Spaniards have cholesterol levels above 200 mg/dl and 20% more than 250 mg/dl. Among schoolchildren, high cholesterol levels affect already at 22%.

About LACER FARMA

LACER Pharma, the pharmaceutical division of laboratories LACER, is a leader in the domestic market in the area of cardiovascular risk, among others, and makes available to health professionals a wide range of pharmaceutical and health products and services with high added value.

LACER, with a turnover in 2010 of 155 million euros, is a Spanish company specialized in the care of human health with a global scope. Its action covers the pharmaceutical industry including the sectors of health and personal hygiene care.

On AB BIOTICS

AB-BIOTICS is a Spanish biotech company focused on research, development, protection and distribution of own and exclusive, biotechnological solutions with the Mission of improving health and well-being of people. From July 2010, AB-BIOTICS is the first biotechnology company with headquarters in Catalonia, and the second in Spain, which is listed in the Stock Exchange alternative market (aim), incorporating companies expanding segment. The company is currently developing a capital increase to boost an international expansion plan that will allow you to have direct presence in countries such as United States, United Kingdom, Germany, France, Turkey, Mexico or Brazil.

Read More

More than half of adults suffers from foot pain.

|

More than half of adults suffers from foot pain

the increase of obesity multiplies the pain and the inflammation.

-biorreguladora medicine manages to regain sensation in areas damaged by osteoarthritis, which suffers from one of every ten people over 60 years

Valencia, 2011-October more than half of adults suffers from foot pain, which in some cases becomes cripplingAccording to experts gathered at the forty-second Congress of podiatry, presented the results of the biorreguladora medicine to combat pain and swelling in the lower extremities. Inappropriate footwear, the sedentary and overweight are some of the most frequent of pain and inflammation of the foot causes, although 60 years predominate because of arthritis.

The increase in overweight and obesity among the population are causing an increase in the pain of feet, according to a study published in the latest issue of the journal Arthritis Care Research. In particular ensures that “ the increase in body mass index, specifically the mass fat Android, is closely associated with sore feet and dysfunctional ”. The study, conducted between subjects aged between 25 and 62, detected that 55 per cent suffering from foot pain.

“ Tight shoes and high heels, in the case of women, leading to many injuries in the foot that may be irreversible ”, according to Alfredo Martínez, general Secretary of the Organising Committee of the Conference. When the heels are very high move the body forward, and concentrated tension on the fingers, the instep and the metatarsus (on the floor), and causes swelling and pain, and over time can lead to irreversible injuries.

“ Therapeutic option for the treatment of painful and inflammatory pictures is the biorregulador drug dispensing in pharmacies, for its effectiveness and its great tolerability of ”, according to the Podiatrist Fernando Ares, who participated in the Congress.

Fernando Ares presented a paper on the benefits of the Biorreguladora medicine on osteoarthritis of the foot, which already affects more than 10% of the population of more than 60 years, according to a study published in the September issue of the Journal of Foot and Anckle Research. However, “ his appearance is becoming more common among people young or middle age due to the current living habits ”, adds this expert.

Regeneration of tissue in arthrosis

So far there is no specific treatment to combat the effects of arthritis in the foot, explains this specialist. “ Available drugs were mainly symptomatic, NSAIDs, but due to the chronic nature of the process, prolonged use of these drugs cause gastrointestinal side effects and, especially, vascular unwanted. However, current research allows us to assert that boiregulators medications are making to unlock the degenerative tendency of the body articulate and rehabilitate the tissue damaged natural and safe ”, says Professor Ares. Research published in biological medicine studied the performance of this medication via injection in condrocitos joints cultivated in vitro and it was observed that it stimulated repair of cartilage articulate injured.

Biorreguladora medicine is an innovative therapeutic system which represents the bridge between homeopathy and conventional medicine. There are homeopathic medicinal compounds, sale in pharmacies, and backed by clinical studies involved in the regulation of the immune system to the different causes that trigger the disease.

Read More

Andalusian neurologists discuss the new therapeutic alternatives for multiple sclerosis in Cádiz

|

Andalusia neurologists discussed in Cadiz on the new alternative therapies for multiple sclerosis
XXXIV meeting of the Andalusian society of Neurology

-in Spain between 35,000 and 40,000 people suffering from this disease

-La Andaluza Neurology society closed its 34TH annual meeting with a round table on new forms of treatment of this disease

-the first oral drug, Fingolimod, has recently been approved by the European Medicines Agency

Cádiz, 2011-October “ multiple sclerosis (MS) has Spain a 3-5 annual incidence cases/100,000 inhabitants and a prevalence of at least 80 cases/100,000 inhabitants, in a way such that, in our country, have the disease a few 35.000/40.000 people and is chronic neurological disease crippling mácommon in young adults s ”, explains Dr. Óscar Fernández in his lecture on new forms of treatment of multiple sclerosis in the XXXIV meeting annual of the society Andalusian of Neurology (SAN), which ended Saturday in the Palace of congresses of Cádiz.

“ At the present time several therapeutic lines can be distinguished. The first are immunomodulators (interferon beta, G intravenous immunoglobulin and plasma exchange and glatiramer acetate). A study has been completed recently, after the first clinical episode of the disease, which demonstrates the usefulness of NBFI-1st sc once or three times per week, which will allow expanding the range of doses available to treat patients since the beginning of the disease. Efficiency is much higher as soon as possible start treatment ”.

“ In the second line are the immunosuppressants, both registered (natalizumab, Mitoxantrone, azathioprine) and unregistered (methotrexate, cyclophosphamide). Recently it has been described an analytical determination allowing employment to safety of natalizumab, very effective drug, which will help improve the treatment of multiple sclerosis immediately. In the third line are located the combined therapy and autologous transplantation of bone marrow, which can be used in the clinic in cases of bad evolution, when other treatments have failed ”, continues Dr. Fernández.

Finally, in the fourth line, are less developed therapies: the neuroprotection and therapy with stem cells, which are unknown to both the efficacy and the toxicity, so it should be considered, today, merely experimental treatments.

“ The European Medicines Agency (EMA) has recently approved the fingolimod for use as a drug of second line, which will mean an important innovation, being the first modern drug by mouth and present very remarkable efficacy and safety data. On this subject has also talked about the left doctor Guillermo, who assured that “ this treatment has shown an efficiency exceeding conventional immunomodulators, with a very good safety profile over the medium term.

Read More
In August II Dentistry in arts

In August II Dentistry in arts

|

The Art Space of the city of Campo Grande MS – opens on August 12 (Friday) the second edition of the exhibition “Dentistry in arts”, which will receive the talents of Dentistry of Mato Grosso do Sul.

In

Are dental surgeons who will exhibit their works, such as wooden sculptures, paintings on canvas, crafts, mosaics, books, dance, music, bonsai,

among others.

Dentists throughout the State will come together to showcase their talents to the population field-grandense, promoting better integration between professionals, who will have the opportunity to confraternizar, revise colleagues and show everyone the

talents.

in addition to the exhibition in the foyer of the House of Laws, on 12 August, 7:30 pm, happens the presentation of the talents of dentistry. Are dental surgeons who will demonstrate their talents, playing piano, guitar, hurdy gurdy, guitar and drums.

dentistry in arts is a realization of the Regional Council of Dentistry of Mato Grosso do Sul (CRO-MS) and has the support of the CFO, ABO-MS, SIOMS, ABCD-MS, UFMS and Uniderp, Anhanguera-Unigran.

 

Service

the opening of the “II Dentistry in arts” happens in the next day, on 12 August, 7:30 pm in Mayor of Campo Grande, located on Rua Ricardo Brandao, n° Jatiúka,

1,600 Park.

 

Read More
Volunteer for research

Volunteer for research

|

The Ribeirão Preto School of dentistry (FORP) recruits volunteers for academic research.

 

Volunteer

In FORP, the researchers Simone Cecilio Hallak Regalo Semprini and Marisa are soliciting men and women, ages 18 years, with hypertension and/or diabetes at least five years ago, with teeth or implant well adapted, to participate in two clinical studies

.

the goal is to analyze the cavity of the mouth and adjacent structures, such as size and function of the muscles of the face, bite force and chewing

these individuals.

the search does not offer dental treatment. Volunteers can sign up by phones (16) 3602.4412 or (16) 3602.4015.

 

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips